SkinHealth Systems Inc. (SKIN) intrinsic value & 10-year financials
SkinHealth Systems Inc. (SKIN) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 8 fiscal years revenue grew 10.3% a year to $300.8M, with an average return on invested capital of 4.4%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $10.56
- Market cap
- $1.4B
- Revenue (FY2025)
- $300.8M
- Revenue growth (8-yr CAGR)
- 10.3%
- ROIC (10-yr avg)
- 4.4%
- Free cash flow (FY2025)
- $37.2M
SKIN 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $300.8M | -$9.5M | -$0.16 | $37.2M | -6.9% | -50.5% |
| FY2024 | $334.3M | -$29.1M | -$0.36 | $15.4M | -20.3% | 63.7% |
| FY2023 | $398.0M | -$100.1M | -$0.76 | $17.9M | -32.9% | 30.7% |
| FY2022 | $365.9M | $44.4M | -$0.23 | -$117.4M | -6.6% | 4.9% |
| FY2021 | $260.1M | -$375.1M | -$3.67 | -$39.6M | -14.1% | 12.5% |
| FY2020 | $119.1M | -$1.1M | -$0.28 | -$15.9M | -1.0% | -34.9% |
| FY2019 | $166.6M | -$1.6M | -$0.02 | -$7.0M | 8.1% | — |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
SkinHealth Systems Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
SkinHealth Systems Inc. has historically struggled to out-earn its cost of capital, averaging just 4.4% ROIC.
SkinHealth Systems Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, SkinHealth Systems Inc. is modeled at 8.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-3.38 per share.